Our results provide a proof-of-concept for a genome-first approach to the identification of hATTR cardiomyopathy and help to inform the potential inclusion of the TTR gene in recommendations on secondary findings reporting and population-based genomic screening analyses. Here, TTR is linked to cardiomyopathy.